Article
CDK7 is a Novel Therapeutic Vulnerability in Fibrolamellar Carcinoma
2023-04-23
Abstract excerpt
<h4>Summary</h4> Fibrolamellar carcinoma (FLC) is a rare and lethal cancer that afflicts young individuals. The tumor arises in the background of a healthy liver, and patients typically present with advanced cancer at the time of diagnosis. Unfortunately, for these patients with advanced or recurrent cancer, no proven systemic therapies exist resulting in only 30-45% of patients surviving to 5 years. Investigatio...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 880ede6b-f31e-5c7e-91ec-61c085d7769f
- DOI
- 10.1101/2023.04.22.537934
